Join to access to all OVN content. Join for Free

Results for 'NCI'

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

ESMO, hematological malignancies, Clinical benefit scale, EHA

The ESMO-MCBS v1.1 has not been previously validated for haematological malignancies, but it is being explored to avoid duplication of efforts. A feasibility test was conducted using 80 studies related to various haematological malignancies such as acute and chronic leukaemia, lymphoma, myel…

Jan 20th • 20 mins read

Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications
OVN Avatar Joseph M. Unger, PhD, MS, Van T. Nghiem, PhD, Dawn L. Hershman, MD, MS
Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications

NCIS, clinical trials, NCTN, drug indications

Importance: NCTN groups are vital in identifying effective new antineoplastic regimens, but their clinical impact has not been systematically evaluated until now. Objective: To determine the association of NCTN trials with guideline care and new drug indications. Design, Setting, and Participant…

Sep 4th • 17 mins read

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

hiring, talent demand, job market

As pipelines advance and execution accelerates, pharma and biotech hiring may shift again in 2026, reshaping talent demand.

Feb 4th • 7 mins read

Leadership Lab: Take a Cue From Athletes by Working With an Executive Coach
Partner Avatar Michael Pietrack
Leadership Lab: Take a Cue From Athletes by Working With an Executive Coach

careers

Executive coaches can help executives take their game to the next level in four key ways, from improving their self-awareness to reshaping their thinking.

Feb 19th • 6 mins read

Leadership Lab: 5 Steps for Building Your Personal Brand
Partner Avatar Michael Pietrack
Leadership Lab: 5 Steps for Building Your Personal Brand

careers

By building and nurturing a strong personal brand, you can benefit in multiple ways, including enhancing your credibility, attracting opportunities and inspiring investor confidence.

Aug 19th • 5 mins read

Leadership Lab: How To Spot When Employees Are About To Walk Away
Partner Avatar Michael Pietrack
Leadership Lab: How To Spot When Employees Are About To Walk Away

careers

Employees rarely leave companies for one reason alone. In this column, Kaye/Bassman’s Michael Pietrack shares a framework that helps leaders identify when their team members are thinking about heading for the exit—and how to address it.

Oct 22nd • 7 mins read

Leadership Lab: 4 Ways Biopharma Leaders Can Prepare for Media Interviews
Partner Avatar Michael Pietrack
Leadership Lab: 4 Ways Biopharma Leaders Can Prepare for Media Interviews

Media coverage can help biopharma executives connect with, inform and inspire the public. In this column, Kaye/Bassman’s Michael Pietrack and three communications experts share how to make the most of these opportunities.

Aug 20th • 6 mins read

Hiring Managers: What Should You Do During a Hiring Freeze?
Partner Avatar Michael Pietrack
Hiring Managers: What Should You Do During a Hiring Freeze?

careers

As we begin 2023, many companies are experiencing hiring freezes. Some hiring managers have a sense of how long the freeze will be, some don’t, but all know that it’s temporary. So, what can hiring managers do during the freeze to stay competitive in the war for talent? Hiring is a competition…

Jan 26th • 5 mins read

Where Did My Interview Go Wrong?
Partner Avatar Tom Caravela
Where Did My Interview Go Wrong?

interview preparation tips, job interview mistakes, hiring manager feedback, candidate interview performance, professional recruiter advice

During the course of a lengthy and involved interview process, job seekers are often left wondering where they went wrong, or why things didn’t pan out positively in their favor – with a great job offer at the end and an exciting next chapter to look forward to in their professional care…

Apr 24th • 1 min read

Interview Differentiator-Be a Story Teller
Partner Avatar Tom Caravela
Interview Differentiator-Be a Story Teller

interview preparation, effective interviewing, behavioral interview questions, storytelling in interviews, successful interview techniques

When you search Google for the words “Interview Preparation,” you will come up with approximately 756,000,000 results. While I am sure you can find an abundance of valuable information, it is very difficult to navigate through all of the content available on the Internet to determine wha…

Mar 22nd • 1 min read

Job Search Checklist for Aspiring Medical Science Liaisons
Partner Avatar Tom Caravela
Job Search Checklist for Aspiring Medical Science Liaisons

Medical Science Liaison, MSL role, MSL career tips, Pharmaceutical industry jobs, Break into MSL career

Tips to Help Break into Your First MSL Role  The Medical Science Liaison (MSL) role, has become one of the most sought-after career paths in the Pharmaceutical and Biotech industry. What does it take to land a role as a Medical Science Liaison? As an MSL Recruiter, this is a question that I am…

May 17th • 2 mins read

MSL Retention – What Matters Most
Partner Avatar Tom Caravela
MSL Retention – What Matters Most

digital marketing, search engine optimization, keyword analysis, content strategy, online visibility

As the Medical Science Liaison job market continues to become more and more competitive, attrition rates continue to increase as a result. One of the most common questions I receive from MSL Directors and Medical Affairs leaders is, “What can we do to keep our MSLs loyal and motivated?” …

Mar 15th • 2 mins read

7 High-Cost Interview Mistakes that are Easy to Avoid
Partner Avatar Tom Caravela
7 High-Cost Interview Mistakes that are Easy to Avoid

digital marketing, content strategy, search engine optimization, keyword research, online visibility

Is your job search taking much longer than expected? Have you gone on interviews and feel it went well, but you still didn’t get the job? Interviewing in a competitive job market can be more challenging than one might think. COVID-19 has not made the interview process any easier – instea…

Jul 28th • 1 min read

MSL Evolution: New Trends and Titles That May Emerge
Partner Avatar Tom Caravela
MSL Evolution: New Trends and Titles That May Emerge

digital marketing strategies, SEO best practices, content marketing tips, social media optimization, keyword research tools

The COVID-19 pandemic has clearly had a profound impact on Field Medical Affairs. Has the Medical Science Liaison role changed forever? What new titles, trends and opportunities might emerge as a result of the new age for Field Medical and the evolution of the Medical Science Liaison? Is virtual en…

Apr 5th • 1 min read

MSL People Skills: Top 10 Tips for Better Engagement
Partner Avatar Tom Caravela
MSL People Skills: Top 10 Tips for Better Engagement

Medical Science Liaison, relationship building, business etiquette, social awareness, emotional intelligence, professional interactions, Dale Carnegie, How to Win Friends and Influence People, professional brand, engagement tips, digital communication

The cornerstone of the Medical Science Liaison role is RELATIONSHIP BUILDING. In a nutshell, better engagement equates to better relationships. The purpose of this article is to address the importance of proper business etiquette and the impact of social awareness and emotional intelligence as it re…

Apr 20th • 8 mins read

Positioning Yourself to Become an MSL in 2022
Partner Avatar Bridget Rasmusson
Positioning Yourself to Become an MSL in 2022

MSL role, clinical background, academic background, research background, industry, MSL Society, conference, scientific expert, therapeutic expertise, pharma companies

After attending the MSL Society’s 9th annual conference in Vegas Last week, I have taken some time to reflect on inquiries our team received about how to effectively step into the MSL role from a clinical, academic, or research background. Industry is a tough nut to crack, but it is absolutely…

Dec 21st • 10 mins read

Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care

Thought Leadership, Oncology

From biomarker-driven breakthroughs to AI-powered early detection and a renewed commitment to equity and patient centricity, the past 12 months have seen major strides across cancer research, treatment, and communication. At Inizio, we’ve had a front-row seat to this transformation, supporting…

May 16th • 5 mins read

Expert perspectives live from ASCO® 2025
Partner Avatar iNIZIO
Expert perspectives live from ASCO® 2025

Thought Leadership, Oncology

At the 2025 ASCO® Annual Meeting, three of our experts sat down with OncoDaily to share their unique perspectives in oncology – from amplifying the patient voice to unlocking real-world impact through data and AI. Watch the videos below. Matthew Hoelzle | Medical strategy, AI and real-wor…

Jul 2nd • 1 min read

Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic
OVN Avatar Charles Oo, Barbara Ameer
Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic

Oncology drug class, Cancer indication, Molecularly targeted, Drug Development

Oncology is the front-line of drug development. The current pharmaceutical pipeline is disproportional focused on oncology, where about 1/3 of all phases of development is in this therapeutic area. The emphasis brings about substantial breakthroughs and has made positive impact on the quality of lif…

Apr 29th • 2 mins read

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
OVN Avatar B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

ESMO-MCBS, bias, clinical trial design, clinical trial implementation, clinical trial reporting, clinical trial analysis

The ESMO-MCBS is a tool used for scoring the clinical benefit of cancer medicines as reported in clinical trials, assuming valid research methodologies and quality implementation. The tool's effectiveness is compromised by studies with flawed design, implementation, or data analysis, w…

Apr 20th • 8 mins read

Related Topics

Meet Our Innovation Partners

Loading partners...